{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:45:14Z","timestamp":1792788314863,"version":"4.5.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the intramural program of the National Cancer Center, Korea","award":["2311430"],"award-info":[{"award-number":["2311430"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Biol"],"DOI":"10.1186\/s13059-025-03882-2","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T13:09:37Z","timestamp":1764594577000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Evaluation of false positive and false negative errors in targeted next generation sequencing"],"prefix":"10.1186","volume":"26","author":[{"given":"Youngbeen","family":"Moon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Kwang","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung Hwan","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Kyung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Won","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong\u2011eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Gu","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namshik","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyeong-Man","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"3882_CR1","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nrg.2016.49","volume":"17","author":"S Goodwin","year":"2016","unstructured":"Goodwin S, McPherson JD, McCombie WR. Coming of age: ten years of next-generation sequencing technologies. Nat Rev Genet. 2016;17:333\u201351.","journal-title":"Nat Rev Genet"},{"key":"3882_CR2","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1002\/cpmb.59","volume":"122","author":"BE Slatko","year":"2018","unstructured":"Slatko BE, Gardner AF, Ausubel FM. Overview of Next-Generation sequencing technologies. Curr Protoc Mol Biol. 2018;122:e59.","journal-title":"Curr Protoc Mol Biol"},{"key":"3882_CR3","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1056\/NEJMra1910138","volume":"381","author":"J Nangalia","year":"2019","unstructured":"Nangalia J, Campbell PJ. Genome sequencing during a patient\u2019s journey through cancer. N Engl J Med. 2019;381:2145\u201356.","journal-title":"N Engl J Med"},{"key":"3882_CR4","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","volume":"578","author":"ITP-CAWG Consortium","year":"2020","unstructured":"Consortium ITP-CAWG. Pan-cancer analysis of whole genomes. Nature. 2020;578:82\u201393.","journal-title":"Nature"},{"key":"3882_CR5","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41586-021-03822-7","volume":"597","author":"L Moore","year":"2021","unstructured":"Moore L, Cagan A, Coorens THH, Neville MDC, Sanghvi R, Sanders MA, Oliver TRW, Leongamornlert D, Ellis P, Noorani A, et al. The mutational landscape of human somatic and germline cells. Nature. 2021;597:381\u20136.","journal-title":"Nature"},{"key":"3882_CR6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/1471-2164-13-341","volume":"13","author":"MA Quail","year":"2012","unstructured":"Quail MA, Smith M, Coupland P, Otto TD, Harris SR, Connor TR, et al. A tale of three next generation sequencing platforms: comparison of ion Torrent, Pacific biosciences and illumina miseq sequencers. BMC Genomics. 2012;13:341.","journal-title":"BMC Genomics"},{"key":"3882_CR7","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jmoldx.2016.07.006","volume":"18","author":"W Mu","year":"2016","unstructured":"Mu W, Lu HM, Chen J, Li S, Elliott AM. Sanger confirmation is required to achieve optimal sensitivity and specificity in next-generation sequencing panel testing. J Mol Diagn. 2016;18:923\u201332.","journal-title":"J Mol Diagn"},{"key":"3882_CR8","doi-asserted-by":"publisher","first-page":"6390","DOI":"10.1158\/0008-5472.CAN-14-1020","volume":"74","author":"AM Hudson","year":"2014","unstructured":"Hudson AM, Yates T, Li Y, Trotter EW, Fawdar S, Chapman P, Lorigan P, Biankin A, Miller CJ, Brognard J. Discrepancies in cancer genomic sequencing highlight opportunities for driver mutation discovery. Cancer Res. 2014;74:6390\u20136.","journal-title":"Cancer Res"},{"key":"3882_CR9","doi-asserted-by":"publisher","first-page":"e0222535","DOI":"10.1371\/journal.pone.0222535","volume":"14","author":"YH Kim","year":"2019","unstructured":"Kim YH, Song Y, Kim JK, Kim TM, Sim HW, Kim HL, et al. False-negative errors in next-generation sequencing contribute substantially to inconsistency of mutation databases. PLoS One. 2019;14:e0222535.","journal-title":"PLoS One"},{"key":"3882_CR10","unstructured":"Food US, Administration D. Considerations for design, development, and analytical validation of next generation sequencing (NGS)-based in vitro diagnostics (IVDs) intended to aid in the diagnosis of suspected germline diseases: guidance for stakeholders and Food and Drug Administration staff. Silver Spring (MD): U.S. Food and Drug Administration; 2018. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/considerations-design-development-and-analytical-validation-next-generation-sequencing-ngs-based."},{"key":"3882_CR11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41525-018-0067-2","volume":"3","author":"F Luh","year":"2018","unstructured":"Luh F, Yen Y. FDA guidance for next generation sequencing-based testing: balancing regulation and innovation in precision medicine. NPJ Genom Med. 2018;3:28.","journal-title":"NPJ Genom Med"},{"key":"3882_CR12","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/gim.2013.92","volume":"15","author":"HL Rehm","year":"2013","unstructured":"Rehm HL, Bale SJ, Bayrak-Toydemir P, Berg JS, Brown KK, Deignan JL, Friez MJ, Funke BH, Hegde MR, Lyon E, et al. ACMG clinical laboratory standards for next-generation sequencing. Genet Med. 2013;15:733\u201347.","journal-title":"Genet Med"},{"key":"3882_CR13","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41587-021-00994-5","volume":"39","author":"W Xiao","year":"2021","unstructured":"Xiao W, Ren L, Chen Z, Fang LT, Zhao Y, Lack J, Guan M, Zhu B, Jaeger E, Kerrigan L, et al. Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing. Nat Biotechnol. 2021;39:1141\u201350.","journal-title":"Nat Biotechnol"},{"key":"3882_CR14","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41597-021-01077-5","volume":"8","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Fang LT, Shen TW, Choudhari S, Talsania K, Chen X, Shetty J, Kriga Y, Tran B, Zhu B, et al. Whole genome and exome sequencing reference datasets from a multi-center and cross-platform benchmark study. Sci Data. 2021;8:296.","journal-title":"Sci Data"},{"key":"3882_CR15","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/s41587-021-00993-6","volume":"39","author":"LT Fang","year":"2021","unstructured":"Fang LT, Zhu B, Zhao Y, Chen W, Yang Z, Kerrigan L, Langenbach K, de Mars M, Lu C, Idler K, et al. Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing. Nat Biotechnol. 2021;39:1151\u201360.","journal-title":"Nat Biotechnol"},{"key":"3882_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13059-021-02316-z","volume":"22","author":"W Jones","year":"2021","unstructured":"Jones W, Gong B, Novoradovskaya N, Li D, Kusko R, Richmond TA, Johann DJ Jr., Bisgin H, Sahraeian SME, Bushel PR, et al. A verified genomic reference sample for assessing performance of cancer panels detecting small variants of low allele frequency. Genome Biol. 2021;22:111.","journal-title":"Genome Biol"},{"key":"3882_CR17","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s13059-021-02528-3","volume":"22","author":"TR Mercer","year":"2021","unstructured":"Mercer TR, Xu J, Mason CE, Tong W, Consortium MS. The sequencing quality control 2 study: establishing community standards for sequencing in precision medicine. Genome Biol. 2021;22:306.","journal-title":"Genome Biol"},{"key":"3882_CR18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13059-019-1676-5","volume":"20","author":"KN Natarajan","year":"2019","unstructured":"Natarajan KN, Miao Z, Jiang M, Huang X, Zhou H, Xie J, Wang C, Qin S, Zhao Z, Wu L, et al. Comparative analysis of sequencing technologies for single-cell transcriptomics. Genome Biol. 2019;20:70.","journal-title":"Genome Biol"},{"key":"3882_CR19","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/s41587-020-00748-9","volume":"39","author":"W Chen","year":"2021","unstructured":"Chen W, Zhao Y, Chen X, Yang Z, Xu X, Bi Y, Chen V, Li J, Choi H, Ernest B, et al. A multicenter study benchmarking single-cell RNA sequencing technologies using reference samples. Nat Biotechnol. 2021;39:1103\u201314.","journal-title":"Nat Biotechnol"},{"key":"3882_CR20","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/s41587-021-00857-z","volume":"39","author":"IW Deveson","year":"2021","unstructured":"Deveson IW, Gong B, Lai K, LoCoco JS, Richmond TA, Schageman J, et al. Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology. Nat Biotechnol. 2021;39:1115\u201328.","journal-title":"Nat Biotechnol"},{"key":"3882_CR21","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/s41587-021-01049-5","volume":"39","author":"J Foox","year":"2021","unstructured":"Foox J, Tighe SW, Nicolet CM, Zook JM, Byrska-Bishop M, Clarke WE, Khayat MM, Mahmoud M, Laaguiby PK, Herbert ZT, et al. Performance assessment of DNA sequencing platforms in the ABRF Next-Generation sequencing study. Nat Biotechnol. 2021;39:1129\u201340.","journal-title":"Nat Biotechnol"},{"key":"3882_CR22","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3343\/alm.2019.39.6.515","volume":"39","author":"H Kim","year":"2019","unstructured":"Kim H, Yun JW, Lee ST, Kim HJ, Kim SH, Kim JW. Korean society for genetic diagnostics clinical guidelines C: Korean society for genetic diagnostics guidelines for validation of Next-Generation Sequencing-Based somatic variant detection in hematologic malignancies. Ann Lab Med. 2019;39:515\u201323.","journal-title":"Ann Lab Med"},{"key":"3882_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4143\/crt.2018.132","volume":"51","author":"SH Lee","year":"2019","unstructured":"Lee SH, Lee B, Shim JH, Lee KW, Yun JW, Kim SY, Kim TY, Kim YH, Ko YH, Chung HC, et al. Landscape of actionable genetic alterations profiled from 1,071 tumor samples in Korean cancer patients. Cancer Res Treat. 2019;51:211\u201322.","journal-title":"Cancer Res Treat"},{"key":"3882_CR24","doi-asserted-by":"publisher","first-page":"7300","DOI":"10.7150\/jca.61324","volume":"12","author":"J Lee","year":"2021","unstructured":"Lee J, Choi S, Jung D, Jung Y, Kim JH, Jung S, Lee WS. Mutational characterization of colorectal cancer from Korean patients with targeted sequencing. J Cancer. 2021;12:7300\u201310.","journal-title":"J Cancer"},{"key":"3882_CR25","doi-asserted-by":"publisher","first-page":"20937","DOI":"10.1038\/s41598-022-24732-2","volume":"12","author":"K Jung","year":"2022","unstructured":"Jung K, Lee S, Na HY, Kim JW, Lee JC, Hwang JH, Kim JW, Kim J. NGS-based targeted gene mutational profiles in Korean patients with pancreatic cancer. Sci Rep. 2022;12:20937.","journal-title":"Sci Rep"},{"key":"3882_CR26","doi-asserted-by":"publisher","first-page":"366","DOI":"10.4048\/jbc.2022.25.e30","volume":"25","author":"KJ Suh","year":"2022","unstructured":"Suh KJ, Kim SH, Kim YJ, Shin H, Kang E, Kim EK, et al. Clinical application of next-generation sequencing in patients with breast cancer: real-world data. J Breast Cancer. 2022;25:366\u201378.","journal-title":"J Breast Cancer"},{"key":"3882_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4143\/crt.2023.844","volume":"56","author":"M Jang","year":"2024","unstructured":"Jang M, Pak HY, Heo JY, Lim H, Choi YL, Shim HS, et al. Trends and clinical characteristics of next-generation sequencing-based genetic panel tests: an analysis of Korean nationwide claims data. Cancer Res Treat. 2024;56:27\u201336.","journal-title":"Cancer Res Treat"},{"key":"3882_CR28","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/bjc.2012.581","volume":"108","author":"R Fisher","year":"2013","unstructured":"Fisher R, Pusztai L, Swanton C. Cancer heterogeneity: implications for targeted therapeutics. Br J Cancer. 2013;108:479\u201385.","journal-title":"Br J Cancer"},{"key":"3882_CR29","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12967-017-1290-9","volume":"15","author":"A Rubben","year":"2017","unstructured":"Rubben A, Araujo A. Cancer heterogeneity: converting a limitation into a source of biologic information. J Transl Med. 2017;15:190.","journal-title":"J Transl Med"},{"key":"3882_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/pcmedi\/pby007","volume":"1","author":"J Zhang","year":"2018","unstructured":"Zhang J, Spath SS, Marjani SL, Zhang W, Pan X. Characterization of cancer genomic heterogeneity by next-generation sequencing advances precision medicine in cancer treatment. Precis Clin Med. 2018;1:29\u201348.","journal-title":"Precis Clin Med"},{"key":"3882_CR31","doi-asserted-by":"publisher","first-page":"103200","DOI":"10.1016\/j.dnarep.2021.103200","volume":"107","author":"A Abbasi","year":"2021","unstructured":"Abbasi A, Alexandrov LB. Significance and limitations of the use of next-generation sequencing technologies for detecting mutational signatures. DNA Repair (Amst). 2021;107:103200.","journal-title":"DNA Repair (Amst)"},{"key":"3882_CR32","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/nbt.2696","volume":"31","author":"GM Frampton","year":"2013","unstructured":"Frampton GM, Fichtenholtz A, Otto GA, Wang K, Downing SR, He J, Schnall-Levin M, White J, Sanford EM, An P, et al. Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nat Biotechnol. 2013;31:1023\u201331.","journal-title":"Nat Biotechnol"},{"key":"3882_CR33","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/s41467-017-01470-y","volume":"8","author":"HT Shin","year":"2017","unstructured":"Shin HT, Choi YL, Yun JW, Kim NKD, Kim SY, Jeon HJ, Nam JY, Lee C, Ryu D, Kim SC, et al. Prevalence and detection of low-allele-fraction variants in clinical cancer samples. Nat Commun. 2017;8:1377.","journal-title":"Nat Commun"},{"key":"3882_CR34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12863-020-00956-x","volume":"22","author":"T Miura","year":"2021","unstructured":"Miura T, Yasuda S, Sato Y. A simple method to estimate the in-house limit of detection for genetic mutations with low allele frequencies in whole-exome sequencing analysis by next-generation sequencing. BMC Genom Data. 2021;22:8.","journal-title":"BMC Genom Data"},{"key":"3882_CR35","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13059-021-02592-9","volume":"23","author":"SME Sahraeian","year":"2022","unstructured":"Sahraeian SME, Fang LT, Karagiannis K, Moos M, Smith S, Santana-Quintero L, Xiao C, Colgan M, Hong H, Mohiyuddin M, Xiao W. Achieving robust somatic mutation detection with deep learning models derived from reference data sets of a cancer sample. Genome Biol. 2022;23:12.","journal-title":"Genome Biol"},{"key":"3882_CR36","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13059-021-02315-0","volume":"22","author":"B Gong","year":"2021","unstructured":"Gong B, Li D, Kusko R, Novoradovskaya N, Zhang Y, Wang S, Pabon-Pena C, Zhang Z, Lai K, Cai W, et al. Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions. Genome Biol. 2021;22:109.","journal-title":"Genome Biol"},{"key":"3882_CR37","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41597-022-01359-6","volume":"9","author":"B Gong","year":"2022","unstructured":"Gong B, Kusko R, Jones W, Tong W, Xu J. Ultra-deep multi-oncopanel sequencing of benchmarking samples with a wide range of variant allele frequencies. Sci Data. 2022;9:288.","journal-title":"Sci Data"},{"key":"3882_CR38","doi-asserted-by":"publisher","first-page":"4973","DOI":"10.1038\/s41598-024-54361-w","volume":"14","author":"W Li","year":"2024","unstructured":"Li W, Huang X, Patel R, Schleifman E, Fu S, Shames DS, et al. Analytical evaluation of circulating tumor DNA sequencing assays. Sci Rep. 2024;14:4973.","journal-title":"Sci Rep"},{"key":"3882_CR39","doi-asserted-by":"publisher","first-page":"e0146638","DOI":"10.1371\/journal.pone.0146638","volume":"11","author":"R Kou","year":"2016","unstructured":"Kou R, Lam H, Duan H, Ye L, Jongkam N, Chen W, Zhang S, Li S. Benefits and challenges with applying unique molecular identifiers in next generation sequencing to detect low frequency mutations. PLoS ONE. 2016;11:e0146638.","journal-title":"PLoS ONE"},{"key":"3882_CR40","doi-asserted-by":"publisher","first-page":"660366","DOI":"10.3389\/fgene.2021.660366","volume":"12","author":"M Tsagiopoulou","year":"2021","unstructured":"Tsagiopoulou M, Maniou MC, Pechlivanis N, Togkousidis A, Kotrova M, Hutzenlaub T, Kappas I, Chatzidimitriou A, Psomopoulos F. UMIc: A preprocessing method for UMI deduplication and reads correction. Front Genet. 2021;12:660366.","journal-title":"Front Genet"},{"key":"3882_CR41","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41592-024-02168-y","volume":"21","author":"J Sun","year":"2024","unstructured":"Sun J, Philpott M, Loi D, Li S, Monteagudo-Mesas P, Hoffman G, Robson J, Mehta N, Gamble V, Brown T Jr., et al. Correcting PCR amplification errors in unique molecular identifiers to generate accurate numbers of sequencing molecules. Nat Methods. 2024;21:401\u20135.","journal-title":"Nat Methods"},{"key":"3882_CR42","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jmoldx.2017.01.011","volume":"19","author":"LJ Jennings","year":"2017","unstructured":"Jennings LJ, Arcila ME, Corless C, Kamel-Reid S, Lubin IM, Pfeifer J, et al. Guidelines for validation of Next-Generation Sequencing-Based oncology panels: a joint consensus recommendation of the association for molecular pathology and college of American pathologists. J Mol Diagn. 2017;19:341\u201365.","journal-title":"J Mol Diagn"},{"key":"3882_CR43","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3389\/fonc.2019.00851","volume":"9","author":"A Petrackova","year":"2019","unstructured":"Petrackova A, Vasinek M, Sedlarikova L, Dyskova T, Schneiderova P, Novosad T, Papajik T, Kriegova E. Standardization of sequencing coverage depth in NGS: recommendation for detection of clonal and subclonal mutations in cancer diagnostics. Front Oncol. 2019;9:851.","journal-title":"Front Oncol"},{"key":"3882_CR44","doi-asserted-by":"publisher","first-page":"997383","DOI":"10.3389\/fgene.2023.997383","volume":"14","author":"D Deshpande","year":"2023","unstructured":"Deshpande D, Chhugani K, Chang Y, Karlsberg A, Loeffler C, Zhang J, Muszynska A, Munteanu V, Yang H, Rotman J, et al. RNA-seq data science: from Raw data to effective interpretation. Front Genet. 2023;14:997383.","journal-title":"Front Genet"},{"key":"3882_CR45","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/ejhg.2015.226","volume":"24","author":"G Matthijs","year":"2016","unstructured":"Matthijs G, Souche E, Alders M, Corveleyn A, Eck S, Feenstra I, Race V, Sistermans E, Sturm M, Weiss M, et al. Guidelines for diagnostic next-generation sequencing. Eur J Hum Genet. 2016;24:2\u20135.","journal-title":"Eur J Hum Genet"},{"key":"3882_CR46","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41436-018-0016-6","volume":"21","author":"P Bauer","year":"2019","unstructured":"Bauer P, Kandaswamy KK, Weiss MER, Paknia O, Werber M, Bertoli-Avella AM, Yuksel Z, Bochinska M, Oprea GE, Kishore S, et al. Development of an evidence-based algorithm that optimizes sensitivity and specificity in ES-based diagnostics of a clinically heterogeneous patient population. Genet Med. 2019;21:53\u201361.","journal-title":"Genet Med"},{"key":"3882_CR47","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1038\/s41467-021-24109-5","volume":"12","author":"A Rose Brannon","year":"2021","unstructured":"Rose Brannon A, Jayakumaran G, Diosdado M, Patel J, Razumova A, Hu Y, Meng F, Haque M, Sadowska J, Murphy BJ, et al. Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS. Nat Commun. 2021;12:3770.","journal-title":"Nat Commun"},{"key":"3882_CR48","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrg.2017.117","volume":"19","author":"JJ Salk","year":"2018","unstructured":"Salk JJ, Schmitt MW, Loeb LA. Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations. Nat Rev Genet. 2018;19:269\u201385.","journal-title":"Nat Rev Genet"},{"key":"3882_CR49","doi-asserted-by":"publisher","first-page":"R32","DOI":"10.1186\/gb-2009-10-3-r32","volume":"10","author":"O Harismendy","year":"2009","unstructured":"Harismendy O, Ng PC, Strausberg RL, Wang X, Stockwell TB, Beeson KY, Schork NJ, Murray SS, Topol EJ, Levy S, Frazer KA. Evaluation of next generation sequencing platforms for population targeted sequencing studies. Genome Biol. 2009;10:R32.","journal-title":"Genome Biol"},{"key":"3882_CR50","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41408-018-0148-6","volume":"8","author":"U Bacher","year":"2018","unstructured":"Bacher U, Shumilov E, Flach J, Porret N, Joncourt R, Wiedemann G, Fiedler M, Novak U, Amstutz U, Pabst T. Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use. Blood Cancer J. 2018;8:113.","journal-title":"Blood Cancer J"},{"key":"3882_CR51","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41551-021-00837-3","volume":"6","author":"P Song","year":"2022","unstructured":"Song P, Wu LR, Yan YH, Zhang JX, Chu T, Kwong LN, Patel AA, Zhang DY. Limitations and opportunities of technologies for the analysis of cell-free DNA in cancer diagnostics. Nat Biomed Eng. 2022;6:232\u201345.","journal-title":"Nat Biomed Eng"},{"key":"3882_CR52","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/nm.3519","volume":"20","author":"AM Newman","year":"2014","unstructured":"Newman AM, Bratman SV, To J, Wynne JF, Eclov NC, Modlin LA, Liu CL, Neal JW, Wakelee HA, Merritt RE, et al. An ultrasensitive method for quantitating Circulating tumor DNA with broad patient coverage. Nat Med. 2014;20:548\u201354.","journal-title":"Nat Med"},{"key":"3882_CR53","doi-asserted-by":"publisher","first-page":"6123","DOI":"10.1038\/s41467-021-26308-6","volume":"12","author":"P Dai","year":"2021","unstructured":"Dai P, Wu LR, Chen SX, Wang MX, Cheng LY, Zhang JX, Hao P, Yao W, Zarka J, Issa GC, et al. Calibration-free NGS quantitation of mutations below 0.01% VAF. Nat Commun. 2021;12:6123.","journal-title":"Nat Commun"},{"key":"3882_CR54","doi-asserted-by":"publisher","first-page":"100106","DOI":"10.1016\/j.crmeth.2021.100106","volume":"1","author":"JC Willey","year":"2021","unstructured":"Willey JC, Morrison TB, Austermiller B, Crawford EL, Craig DJ, Blomquist TM, Jones WD, Wali A, Lococo JS, Haseley N, et al. Advancing NGS quality control to enable measurement of actionable mutations in Circulating tumor DNA. Cell Rep Methods. 2021;1:100106.","journal-title":"Cell Rep Methods"},{"key":"3882_CR55","doi-asserted-by":"crossref","unstructured":"Cheng C, Xiao P. Evaluation of the correctable decoding sequencing as a new powerful strategy for DNA sequencing. Life Sci Alliance. 2022;5:e202101294.","DOI":"10.26508\/lsa.202101294"},{"key":"3882_CR56","doi-asserted-by":"publisher","first-page":"982111","DOI":"10.3389\/fbioe.2023.982111","volume":"11","author":"C Cheng","year":"2023","unstructured":"Cheng C, Fei Z, Xiao P. Methods to improve the accuracy of next-generation sequencing. Front Bioeng Biotechnol. 2023;11:982111.","journal-title":"Front Bioeng Biotechnol"},{"key":"3882_CR57","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/jhg.2015.102","volume":"60","author":"K Hosomichi","year":"2015","unstructured":"Hosomichi K, Shiina T, Tajima A, Inoue I. The impact of next-generation sequencing technologies on HLA research. J Hum Genet. 2015;60:665\u201373.","journal-title":"J Hum Genet"},{"key":"3882_CR58","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.jmoldx.2016.03.009","volume":"18","author":"ET Weimer","year":"2016","unstructured":"Weimer ET, Montgomery M, Petraroia R, Crawford J, Schmitz JL. Performance characteristics and validation of Next-Generation sequencing for human leucocyte antigen typing. J Mol Diagn. 2016;18:668\u201375.","journal-title":"J Mol Diagn"},{"key":"3882_CR59","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12859-017-1671-3","volume":"18","author":"S Ka","year":"2017","unstructured":"Ka S, Lee S, Hong J, Cho Y, Sung J, Kim HN, et al. Hlascan: genotyping of the HLA region using next-generation sequencing data. BMC Bioinformatics. 2017;18:258.","journal-title":"BMC Bioinformatics"},{"key":"3882_CR60","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12920-024-01808-8","volume":"17","author":"A Sverchkova","year":"2024","unstructured":"Sverchkova A, Burkholz S, Rubsamen R, Stratford R, Clancy T. Integrative HLA typing of tumor and adjacent normal tissue can reveal insights into the tumor immune response. BMC Med Genomics. 2024;17:37.","journal-title":"BMC Med Genomics"},{"key":"3882_CR61","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13059-020-02038-8","volume":"21","author":"C Groza","year":"2020","unstructured":"Groza C, Kwan T, Soranzo N, Pastinen T, Bourque G. Personalized and graph genomes reveal missing signal in epigenomic data. Genome Biol. 2020;21:124.","journal-title":"Genome Biol"},{"key":"3882_CR62","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13073-020-00791-w","volume":"12","author":"DC Koboldt","year":"2020","unstructured":"Koboldt DC. Best practices for variant calling in clinical sequencing. Genome Med. 2020;12:91.","journal-title":"Genome Med"},{"key":"3882_CR63","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41586-018-0409-3","volume":"560","author":"U Ben-David","year":"2018","unstructured":"Ben-David U, Siranosian B, Ha G, Tang H, Oren Y, Hinohara K, Strathdee CA, Dempster J, Lyons NJ, Burns R, et al. Genetic and transcriptional evolution alters cancer cell line drug response. Nature. 2018;560:325\u201330.","journal-title":"Nature"},{"key":"3882_CR64","unstructured":"Li H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. In arXiv e-prints, vol. arXiv:1303.3997; 2013."},{"key":"3882_CR65","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, DePristo MA. The genome analysis toolkit: a mapreduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297\u2013303.","journal-title":"Genome Res"},{"key":"3882_CR66","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ng.806","volume":"43","author":"MA DePristo","year":"2011","unstructured":"DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, Philippakis AA, del Angel G, Rivas MA, Hanna M, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet. 2011;43:491\u20138.","journal-title":"Nat Genet"},{"key":"3882_CR67","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/hdy.2016.102","volume":"118","author":"SP Pfeifer","year":"2017","unstructured":"Pfeifer SP. From next-generation resequencing reads to a high-quality variant data set. Heredity (Edinb). 2017;118:111\u201324.","journal-title":"Heredity (Edinb)"},{"key":"3882_CR68","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.tig.2018.04.005","volume":"34","author":"M Tomkova","year":"2018","unstructured":"Tomkova M, Schuster-Bockler B. DNA modifications: naturally more error prone? Trends Genet. 2018;34:627\u201338.","journal-title":"Trends Genet"},{"key":"3882_CR69","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13059-020-02254-2","volume":"22","author":"EM Davis","year":"2021","unstructured":"Davis EM, Sun Y, Liu Y, Kolekar P, Shao Y, Szlachta K, et al. Sequencerr: measuring and suppressing sequencer errors in next-generation sequencing data. Genome Biol. 2021;22:37.","journal-title":"Genome Biol"},{"key":"3882_CR70","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13059-022-02709-8","volume":"23","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Blomquist TM, Kusko R, Stetson D, Zhang Z, Yin L, Sebra R, Gong B, Lococo JS, Mittal VK, et al. Deep oncopanel sequencing reveals within block position-dependent quality degradation in FFPE processed samples. Genome Biol. 2022;23:141.","journal-title":"Genome Biol"},{"key":"3882_CR71","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41698-024-00553-6","volume":"8","author":"F Markowetz","year":"2024","unstructured":"Markowetz F. All models are wrong and yours are useless: making clinical prediction models impactful for patients. NPJ Precis Oncol. 2024;8:54.","journal-title":"NPJ Precis Oncol"},{"key":"3882_CR72","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/s41587-024-02382-1","volume":"43","author":"S Behera","year":"2025","unstructured":"Behera S, Catreux S, Rossi M, Truong S, Huang Z, Ruehle M, Visvanath A, Parnaby G, Roddey C, Onuchic V, et al. Comprehensive genome analysis and variant detection at scale using DRAGEN. Nat Biotechnol. 2025;43:1177\u201391.","journal-title":"Nat Biotechnol"},{"key":"3882_CR73","doi-asserted-by":"crossref","unstructured":"Moon Y, Kim YH, Kim JK, Hong CH, Kang EK, Choi HW, Lee D-E, Kim T-M, Heo SG, Han N, Hong K-M. Evaluation of false positive and false negative errors in targeted next generation sequencing. Datasets. NCBI Seq Read Archive 2024, PRJNA1134909 (https:\/\/www.ncbi.nlm.nih.gov\/sra\/PRJNA1134909).","DOI":"10.1101\/2024.07.22.603478"}],"container-title":["Genome Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13059-025-03882-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13059-025-03882-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13059-025-03882-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T15:04:43Z","timestamp":1764601483000},"score":1,"resource":{"primary":{"URL":"https:\/\/genomebiology.biomedcentral.com\/articles\/10.1186\/s13059-025-03882-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3882"],"URL":"https:\/\/doi.org\/10.1186\/s13059-025-03882-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.07.22.603478","asserted-by":"object"}]},"ISSN":["1474-760X"],"issn-type":[{"value":"1474-760X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"31 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Blood samples were obtained with informed consent, and the study received approval from the Institutional Review Board (IRB) of the National Cancer Center in Korea.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read and approved the final manuscript. All participants provided consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"409"}}